TipHub

₹162.18

▲ +3.18 +2.00%

As of 27 Jul 2026 · delayed

NSE Listed

ESM · ESM 2
What does ESM · ESM 2 mean?
BSE · Enhanced Surveillance Measure (ESM 2)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-10
NSE · Enhanced Surveillance Measure (ESM 2)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-14

Amanta Healthcare Limited (AMANTA)

Volume: 35,055Avg Vol 1W: 26,325.4Avg Vol 1M: 86,239.752W Range:₹92₹189
NSE BSE www.amanta.co.in AI Report
Key Ratios
Checked 2d ago
Market Cap₹633 Cr
Current Price₹162.18
Previous Close₹159
High / Low (52w)₹189 / ₹92
Volume35,055
Avg Vol (1W)26,325.4
Avg Vol (1M)86,239.7
Stock P/E99.38
Book Value₹56.71
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹276 Cr
Revenue Growth—
Profit Margin—
Total Debt₹244 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹1.61
P/B2.82
Debt / Equity—
50 DMA₹155.84
200 DMA₹123.75
Day change+2.00%
SurveillanceESM · ESM 2
Price Chart
₹162.18▲ 14.41% · 1Y
₹186₹9560.1L
2025-09-09
2026-07-27

20-day avg volume: 86K shares

Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 99.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹68 Cr₹67 Cr₹68 Cr₹72 Cr₹65 Cr₹71 Cr₹74 Cr₹77 Cr
EBITDA₹9 Cr₹9 Cr₹11 Cr₹14 Cr₹11 Cr₹10 Cr₹11 Cr₹12 Cr
Net Profit₹0 Cr₹2 Cr₹4 Cr₹6 Cr₹4 Cr₹1 Cr₹5 Cr₹6 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹187 Cr₹172 Cr₹227 Cr₹263 Cr₹282 Cr₹276 Cr
EBITDA₹23 Cr₹22 Cr₹36 Cr₹38 Cr₹39 Cr₹43 Cr
Net Profit₹-19 Cr₹-22 Cr₹55 Cr₹-2 Cr₹4 Cr₹11 Cr
EPS-7.04-8.1420.54-0.791.353.71
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹388 Cr₹392 Cr₹392 Cr₹374 Cr₹352 Cr₹382 Cr₹558 Cr
Total Liabilities₹359 Cr₹385 Cr₹320 Cr₹311 Cr₹286 Cr₹285 Cr₹338 Cr
Equity₹29 Cr₹7 Cr₹72 Cr₹63 Cr₹66 Cr₹96 Cr₹220 Cr
Total Debt——————₹244 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹26 Cr₹137 Cr₹49 Cr₹64 Cr₹50 Cr₹48 Cr
Investing₹-16 Cr₹-5 Cr₹-7 Cr₹-10 Cr₹-24 Cr₹-94 Cr
Financing₹-18 Cr₹-50 Cr₹-42 Cr₹-46 Cr₹-23 Cr₹126 Cr
Free Cash Flow₹26 Cr₹137 Cr₹49 Cr₹64 Cr₹50 Cr₹-32 Cr
Shareholding
Promoter 63.8% Institutions 13.35% Public 22.85%
About Amanta Healthcare Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, leur-lock, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.

www.amanta.co.in ↗
Efficiency & Working Capital
ROCE14.8%
Interest Coverage1.5
Dividend Payout—
Debtor Days67 d
Inventory Days97 d
Payable Days41 d
Cash Conversion Cycle123 d
Working Capital Days164 d
Shareholding Details

As of 2026-06-30

Promoter63.8%
FII0.4%
DII12.9%
Institutions13.4%
Public22.8%
Promoter Pledge0%
No. of Shareholders12,612
Shareholding Pattern

Quarterly — figures in %. Latest 9 quarters.

PeriodSept 2024Feb 2025Jun 2025Aug 2025Aug 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters85.5%85.5%63.6%85.6%85.6%63.6%63.6%63.7%63.8%
FIIs0%0%2.2%0%0%1%1.1%0.8%0.4%
DIIs0%0%12.2%14.4%0%11.3%11.2%12.9%12.9%
Public14.5%14.5%22%0%14.4%24.1%24.1%22.6%22.8%
Promoter Pledge0%25.3%0%25.2%25.2%0%0%0%0%
No. of Shareholders19220030,69536136118,66916,18115,22212,612
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Bhavesh Girishbhai PatelShareholding of Promoter and Promoter Group16.3%63,32,179
Vishal Ashokkumar PatelShareholding of Promoter and Promoter Group10.1%39,05,288
Jitendrakumar Jashbhai PatelShareholding of Promoter and Promoter Group9%35,02,038
Milcent Appliances Private LimitedShareholding of Promoter and Promoter Group8%31,00,000
Praful Jashbhai PatelShareholding of Promoter and Promoter Group5.9%22,82,264
Bandhan Small Cap FundPublic Shareholding5.3%20,67,840
Pravinchandra Dhanjibhai MehtaShareholding of Promoter and Promoter Group5.1%19,82,763
Niranjanbhai Ishwarbhai PatelShareholding of Promoter and Promoter Group3.9%15,04,951
Kirit Ambalal DesaiShareholding of Promoter and Promoter Group2.9%11,27,079
Jayshreeben Rohitkumar PatelShareholding of Promoter and Promoter Group2.6%9,98,109
Perpetuity Health To Wealth (h2w) Rising FundPublic Shareholding1.8%7,10,000
Finavenue Capital Trust - Finavenue Growth FundPublic Shareholding1.8%6,98,956
Aarth Aif Growth FundPublic Shareholding1.7%6,74,000
Darpana J. PatelShareholding of Promoter and Promoter Group0.1%25,163
Sarala Kirit DesaiShareholding of Promoter and Promoter Group0%12,024
Jatin Kumar J MehtaShareholding of Promoter and Promoter Group0%2,000
Manisha B PatelShareholding of Promoter and Promoter Group0%1
Pramilaben PatelShareholding of Promoter and Promoter Group0%0
Devashish PatelShareholding of Promoter and Promoter Group0%0
J R MehtaShareholding of Promoter and Promoter Group0%0
Bharati MehtaShareholding of Promoter and Promoter Group0%0
Milcent Jansewa FoundationShareholding of Promoter and Promoter Group0%0
Magtech Motors Private LimitedShareholding of Promoter and Promoter Group0%0
Veenaben Jitendrakumar PatelShareholding of Promoter and Promoter Group0%1
Donikaben PatelShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Bhavesh PatelChairman & Managing Director2025
Nimesh PatelNon-Exec & Non-Independent Dir2025
Kshitij PatelIndependent Non Exe. Director2025
Anjali N. ChoksiIndependent Director2025
Nitin JainIndependent Director2025
Pratik GandhiNon Executive Director2025
Nikhita DinodiaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing and sale of pharmaceu₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹181 Cr66.6%
Outside India₹91 Cr33.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10802929
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000404
2025000101
2025000101
Insider / Designated-Person Trades

5 recent disclosure(s)

Jitendrakumar Jashbhai PatelAcquisition · 16,200
Kirit Ambalal DesaiDisposal · 5,000
Bhavesh Girishbhai PatelAcquisition · 28,800
Dympal JainAcquisition · 15,675
Bhavesh Girishbahi PatelAcquisition · 48,151
Substantial Acquisitions (SAST)

1 disclosure(s)

Market25/03/2026 · 21,603
Company Information
Incorporated1994
ChairmanBhavesh Patel
AuditorPrice Waterhouse Chartered Accountants LLP
Investor Email[email protected]
🌐 www.amanta.co.in ↗

📍 8th Floor Shaligram Corporates, C.J.Marg Ambli, Ahmedabad, Gujarat, 380058

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

AAFS MARKET LINK2027SR IAlphageo (India) LimitedAlpine Texworld LimitedAlpine Texworld LimitedAluwind Infra-Tech Ltd.Amagi Media Labs LimitedAmba Auto Sales and Services Ltd.Ambalal Sarabhai Enterprises Ltd.Ambani Orgochem LimitedAmber Enterprises India Ltd.Ambica Agarbathies Aroma & Industries Ltd.Ambika Cotton Mill Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search